Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection

Creative Commons License

Pepeler M. S. , YILDIZ Ş., YEGİN Z. A. , ÖZKURT Z. N. , GÜZEL TUNÇCAN Ö., ERBAŞ G., ...More

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.12, no.9, pp.799-805, 2018 (SCI-Expanded) identifier identifier identifier


Introduction: Invasive fungal infection (IFI) is a major cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. A previous history of IFI is not an absolute contraindication for allo-HSCT, particularly in the era of secondary antifungal prophylaxis (SAP). Prompt diagnosis and therapy are essential for HSCT outcome.